Paper28796249
Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation.
Ziegler V and 6 others. Cell Death Dis, 2017. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation. Papers, record 28796249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28796249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| DNA Breaks, Double-Stranded | Major topic |
| DNA Damage | Major topic |
| Lovastatin | Major topic |
| Animals | |
| Body Weight | |
| Cells, Cultured | |
| DNA Repair | |
| Human Umbilical Vein Endothelial Cells | |
| Humans | |
| Lung | |
| Mice | |
| Mice, Inbred BALB C | |
| Oxidative Stress | |
| Pyrones | |
| Quality of Life | |
| Quinolines | |
| Signal Transduction | |
| rho GTP-Binding Proteins |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27181206 | RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. | Oncogene | 2016 | https://conductscience.org/library/papers/27181206 | PubMed |
| 2 | 26437439 | Rho GTPases: Novel Players in the Regulation of the DNA Damage Response? | Biomolecules | 2015 | https://conductscience.org/library/papers/26437439 | PubMed |
| 3 | 21258249 | Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression. | J Thorac Oncol | 2011 | https://conductscience.org/library/papers/21258249 | PubMed |
| 4 | 15531395 | Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. | Cancer Treat Rev | 2004 | https://conductscience.org/library/papers/15531395 | PubMed |
| 5 | 20659133 | Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. | Clin Exp Pharmacol Physiol | 2010 | https://conductscience.org/library/papers/20659133 | PubMed |
| 6 | 28277539 | Epidermal Rac1 regulates the DNA damage response and protects from UV-light-induced keratinocyte apoptosis and skin carcinogenesis. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28277539 | PubMed |
| 7 | 10328216 | Rho GTPases are over-expressed in human tumors. | Int J Cancer | 1999 | https://conductscience.org/library/papers/10328216 | PubMed |
| 8 | 20424337 | Pleiotropic effects of statins. - Basic research and clinical perspectives -. | Circ J | 2010 | https://conductscience.org/library/papers/20424337 | PubMed |
| 9 | 21833028 | Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/21833028 | PubMed |
| 10 | 17088865 | Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/17088865 | PubMed |
| 11 | 9816194 | Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. | Clin Cancer Res | 1996 | https://conductscience.org/library/papers/9816194 | PubMed |
| 12 | 14575837 | Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. | Int J Radiat Oncol Biol Phys | 2003 | https://conductscience.org/library/papers/14575837 | PubMed |
| 13 | 26679354 | Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function. | Stem Cells | 2016 | https://conductscience.org/library/papers/26679354 | PubMed |
| 14 | 16211237 | HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). | Int J Oncol | 2005 | https://conductscience.org/library/papers/16211237 | PubMed |
| 15 | 23012366 | Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons. | J Biol Chem | 2012 | https://conductscience.org/library/papers/23012366 | PubMed |
| 16 | 18082599 | The DNA damage response: ten years after. | Mol Cell | 2007 | https://conductscience.org/library/papers/18082599 | PubMed |
| 17 | 24786604 | Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). | Br J Cancer | 2014 | https://conductscience.org/library/papers/24786604 | PubMed |
| 18 | 19615773 | Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. | Radiother Oncol | 2009 | https://conductscience.org/library/papers/19615773 | PubMed |
| 19 | 15710979 | Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. | Gut | 2005 | https://conductscience.org/library/papers/15710979 | PubMed |
| 20 | 20921821 | Protective effect of atorvastatin on radiation-induced vascular endothelial cell injury in vitro. | J Radiat Res | 2010 | https://conductscience.org/library/papers/20921821 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41897526 | Radiomitigators: Breakthroughs in Post-Radiation Recovery. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41897526 | PubMed |
| 41507636 | Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41507636 | PubMed |
| 41487529 | Research progress in the prevention and treatment of radiation-induced heart disease. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41487529 | PubMed |
| 41294814 | Radiation Without Borders: Unraveling Bystander and Non-Targeted Effects in Oncology. | Cells | 2025 | https://conductscience.org/library/papers/41294814 | PubMed |
| 40357679 | Intersection of Cardio-Oncology: An Overview of Radiation-Induced Heart Disease in the Context of Tumors. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/40357679 | PubMed |
| 39392173 | Statin Therapy Reduces Radiation-Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/39392173 | PubMed |
| 39005681 | Statin therapy enhances survival in unresectable stage III lung squamous cell carcinoma with concurrent chemoradiotherapy. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39005681 | PubMed |
| 37446385 | A Cross-Talk about Radioresistance in Lung Cancer-How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446385 | PubMed |
| 37026495 | Crosstalk between Oxidative Stress and Inflammation Induced by Ionizing Radiation in Healthy and Cancerous Cells. | Curr Med Chem | 2024 | https://conductscience.org/library/papers/37026495 | PubMed |
| 36979459 | Molecular Influence of the ATM Protein in the Treatment of Human Cells with Different Radioprotective Drugs: Comparisons between Antioxidative and Pro-Episkevic Strategies. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979459 | PubMed |
| 36972439 | Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36972439 | PubMed |
| 36799170 | Radioprotective countermeasures for radiation injury (Review). | Mol Med Rep | 2023 | https://conductscience.org/library/papers/36799170 | PubMed |
| 36051660 | Screen identifies fasudil as a radioprotector on human fibroblasts. | Toxicol Res (Camb) | 2022 | https://conductscience.org/library/papers/36051660 | PubMed |
| 34773069 | Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis. | Lab Invest | 2022 | https://conductscience.org/library/papers/34773069 | PubMed |
| 34696890 | Atorvastatin and blood flow regulate expression of distinctive sets of genes in mouse carotid artery endothelium. | Curr Top Membr | 2021 | https://conductscience.org/library/papers/34696890 | PubMed |
| 34084138 | Extracellular Vesicles for the Treatment of Radiation Injuries. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34084138 | PubMed |
| 34079763 | Rac1, A Potential Target for Tumor Therapy. | Front Oncol | 2021 | https://conductscience.org/library/papers/34079763 | PubMed |
| 33803333 | Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33803333 | PubMed |
| 31757180 | DNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genes. | Cell Cycle | 2020 | https://conductscience.org/library/papers/31757180 | PubMed |
| 31467399 | Ionizing Radiation induction of cholesterol biosynthesis in Lung tissue. | Sci Rep | 2019 | https://conductscience.org/library/papers/31467399 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28796249
GET https://conductscience.org/api/papers/v1/28796249/references?page=2